BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodriguez-Ruiz ME, Vitale I, Harrington KJ, Melero I, Galluzzi L. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nat Immunol 2020;21:120-34. [PMID: 31873291 DOI: 10.1038/s41590-019-0561-4] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 21.3] [Reference Citation Analysis]
Number Citing Articles
1 Li G, Yang M, Ran L, Jin F. Expression profile of radiotherapy sensitive genes and tumor-associated immune cell infiltration and prognosis in multiple human cancers. Journal of Radiation Research and Applied Sciences 2022;15:5-11. [DOI: 10.1016/j.jrras.2022.05.016] [Reference Citation Analysis]
2 Wang L, Yuan W, Li L, Shen Z, Geng Q, Zheng Y, Zhao J, Behzadi P. Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/9544827] [Reference Citation Analysis]
3 Zhang S, Zhang J, Fan X, Liu H, Zhu M, Yang M, Zhang X, Zhang H, Yu F. Ionizing Radiation-Induced Ferroptosis Based on Nanomaterials. IJN 2022;Volume 17:3497-507. [DOI: 10.2147/ijn.s372947] [Reference Citation Analysis]
4 Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol 2022. [PMID: 35879417 DOI: 10.1038/s41577-022-00760-x] [Reference Citation Analysis]
5 Sun S, Gu W, Wu H, Zhao Q, Qian S, Xiao H, Yang K, Liu J, Jin Y, Hu C, Gao Y, Xu H, Liu H, Ji J, Chen Y. Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection. Adv Funct Materials. [DOI: 10.1002/adfm.202205038] [Reference Citation Analysis]
6 Xu W, Tang H, Anwaier A, Liu W, Tian X, Su J, Wei S, Qu Y, Zhang H, Ye D. Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer. Front Immunol 2022;13:909324. [DOI: 10.3389/fimmu.2022.909324] [Reference Citation Analysis]
7 Ye J, Mills BN, Qin SS, Garrett-Larsen J, Murphy JD, Uccello TP, Han BJ, Vrooman TG, Johnston CJ, Lord EM, Belt BA, Linehan DC, Gerber SA. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. J Immunother Cancer 2022;10:e004784. [PMID: 35851308 DOI: 10.1136/jitc-2022-004784] [Reference Citation Analysis]
8 Petricevic B, Kabiljo J, Zirnbauer R, Walczak H, Laengle J, Bergmann M. Neoadjuvant Immunotherapy in Gastrointestinal Cancers - The New Standard of Care? Semin Cancer Biol 2022:S1044-579X(22)00126-2. [PMID: 35671877 DOI: 10.1016/j.semcancer.2022.05.015] [Reference Citation Analysis]
9 Liu R, Gong L, Zhu X, Zhu S, Wu X, Xue T, Yan L, Du J, Gu Z. Transformable Gallium-Based Liquid Metal Nanoparticles for Tumor Radiotherapy Sensitization. Adv Healthc Mater 2022;11:e2102584. [PMID: 35114075 DOI: 10.1002/adhm.202102584] [Reference Citation Analysis]
10 Bezu L, Kepp O, Kroemer G. Immunogenic stress induced by local anesthetics injected into neoplastic lesions. OncoImmunology 2022;11:2077897. [DOI: 10.1080/2162402x.2022.2077897] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jia Q, Wang A, Yuan Y, Zhu B, Long H. Heterogeneity of the tumor immune microenvironment and its clinical relevance. Exp Hematol Oncol 2022;11:24. [PMID: 35461288 DOI: 10.1186/s40164-022-00277-y] [Reference Citation Analysis]
12 Bell CR, Pelly VS, Moeini A, Chiang SC, Flanagan E, Bromley CP, Clark C, Earnshaw CH, Koufaki MA, Bonavita E, Zelenay S. Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations. Nat Commun 2022;13:2063. [PMID: 35440553 DOI: 10.1038/s41467-022-29606-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang L, Jiang J, Chen Y, Jia Q, Chu Q. The roles of CC chemokines in response to radiation. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-02038-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang Y, Chen J, Duan R, Gu R, Wang W, Wu J, Lian H, Hu Y, Yuan A. High-Z-Sensitized Radiotherapy Synergizes with the Intervention of the Pentose Phosphate Pathway for In Situ Tumor Vaccination. Adv Mater 2022;34:e2109726. [PMID: 35102614 DOI: 10.1002/adma.202109726] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Charpentier M, Spada S, Vannest S, Demaria S. Radiation therapy-induced remodeling of the tumor immune microenvironment. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhuang F, Ma Q, Dong C, Xiang H, Shen Y, Sun P, Li C, Chen Y, Lu B, Chen Y, Huang B. Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy. ACS Nano 2022. [PMID: 35357810 DOI: 10.1021/acsnano.1c09505] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Petroni G, Buqué A, Coussens LM, Galluzzi L. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat Rev Drug Discov 2022. [PMID: 35292771 DOI: 10.1038/s41573-022-00415-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
18 O'neill E, Cornelissen B. Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy. Nuclear Medicine and Biology 2022. [DOI: 10.1016/j.nucmedbio.2022.02.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kumari N, Choi SH. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-022-02272-x] [Reference Citation Analysis]
20 Fucikova J, Palova-Jelinkova L, Klapp V, Holicek P, Lanickova T, Kasikova L, Drozenova J, Cibula D, Álvarez-Abril B, García-Martínez E, Spisek R, Galluzzi L. Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends Cancer 2022:S2405-8033(22)00017-6. [PMID: 35181272 DOI: 10.1016/j.trecan.2022.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol 2022. [PMID: 35145297 DOI: 10.1038/s41590-022-01132-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 41.0] [Reference Citation Analysis]
22 Parikh AR, Szabolcs A, Allen JN, Clark JW, Wo JY, Raabe M, Thel H, Hoyos D, Mehta A, Arshad S, Lieb DJ, Drapek LC, Blaszkowsky LS, Giantonio BJ, Weekes CD, Zhu AX, Goyal L, Nipp RD, Dubois JS, Van Seventer EE, Foreman BE, Matlack LE, Ly L, Meurer JA, Hacohen N, Ryan DP, Yeap BY, Corcoran RB, Greenbaum BD, Ting DT, Hong TS. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat Cancer 2021;2:1124-35. [PMID: 35122060 DOI: 10.1038/s43018-021-00269-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
23 Zhang H, Kong W, Zhao X, Han C, Liu T, Li J, Song D. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer. BMC Genom Data 2022;23:8. [PMID: 35042477 DOI: 10.1186/s12863-022-01024-2] [Reference Citation Analysis]
24 Xu J, Ma Q, Zhang Y, Fei Z, Sun Y, Fan Q, Liu B, Bai J, Yu Y, Chu J, Chen J, Wang C. Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth. Nat Commun 2022;13:110. [PMID: 35013252 DOI: 10.1038/s41467-021-27750-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
25 Li H, Wang M, Huang B, Zhu SW, Zhou JJ, Chen DR, Cui R, Zhang M, Sun ZJ. Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis. Nat Commun 2021;12:7149. [PMID: 34887404 DOI: 10.1038/s41467-021-27485-0] [Reference Citation Analysis]
26 Wan C, Sun Y, Hu Y, Huang J, Lu L, Gao Y, Zi H, He Q, Sun J, Lovell JF, Yang K, Jin H. Peptide hydrogels loaded with irradiated tumor cell secretions enhance cancer immunotherapy. Nano Today 2021;41:101323. [DOI: 10.1016/j.nantod.2021.101323] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Petroni G, Cantley LC, Santambrogio L, Formenti SC, Galluzzi L. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol 2021. [PMID: 34819622 DOI: 10.1038/s41571-021-00579-w] [Reference Citation Analysis]
28 Scheidegger S, Mingo Barba S, Gaipl US. Theoretical Evaluation of the Impact of Hyperthermia in Combination with Radiation Therapy in an Artificial Immune-Tumor-Ecosystem. Cancers (Basel) 2021;13:5764. [PMID: 34830918 DOI: 10.3390/cancers13225764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Humeau J, Le Naour J, Galluzzi L, Kroemer G, Pol JG. Trial watch: intratumoral immunotherapy. Oncoimmunology 2021;10:1984677. [PMID: 34676147 DOI: 10.1080/2162402X.2021.1984677] [Reference Citation Analysis]
30 Hellevik T, Berzaghi R, Lode K, Islam A, Martinez-Zubiaurre I. Immunobiology of cancer-associated fibroblasts in the context of radiotherapy. J Transl Med 2021;19:437. [PMID: 34663337 DOI: 10.1186/s12967-021-03112-w] [Reference Citation Analysis]
31 Averbeck D, Rodriguez-Lafrasse C. Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts. Int J Mol Sci 2021;22:11047. [PMID: 34681703 DOI: 10.3390/ijms222011047] [Reference Citation Analysis]
32 Yang Y, Wu M, Cao D, Yang C, Jin J, Wu L, Hong X, Li W, Lu L, Li J, Wang X, Meng X, Zhang Z, Cheng J, Ye Y, Xiao H, Yu J, Deng L. ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation. Sci Adv 2021;7:eabf6290. [PMID: 34613770 DOI: 10.1126/sciadv.abf6290] [Reference Citation Analysis]
33 Tung LT, Wang H, Belle JI, Petrov JC, Langlais D, Nijnik A. p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress. Cell Death Dis 2021;12:923. [PMID: 34625535 DOI: 10.1038/s41419-021-04202-9] [Reference Citation Analysis]
34 Lecoultre M, Dutoit V, Walker PR. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. J Immunother Cancer 2020;8:e001408. [PMID: 33335026 DOI: 10.1136/jitc-2020-001408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Zhou J, Yang Q, Lu L, Tuo Z, Shou Z, Cheng J. PLK1 Inhibition Induces Immunogenic Cell Death and Enhances Immunity against NSCLC. Int J Med Sci 2021;18:3516-25. [PMID: 34522178 DOI: 10.7150/ijms.60135] [Reference Citation Analysis]
36 Yasmin-Karim S, Ziberi B, Wirtz J, Bih N, Moreau M, Guthier R, Ainsworth V, Hesser J, Makrigiorgos GM, Chuong MD, Wei X, Nguyen PL, Ngwa W. Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02793-0. [PMID: 34530092 DOI: 10.1016/j.ijrobp.2021.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Zhu M, Yang M, Zhang J, Yin Y, Fan X, Zhang Y, Qin S, Zhang H, Yu F. Immunogenic Cell Death Induction by Ionizing Radiation. Front Immunol 2021;12:705361. [PMID: 34489957 DOI: 10.3389/fimmu.2021.705361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Li D, Guan Y, Dong Y, Wu J, Zhang Y, Chen R, Lin YT, Fornace AJ, Li HH, Yuan Z. Radiochemotherapy upregulates expression of checkpoint receptors on circulating T cells. Int J Radiat Biol 2021;:1-6. [PMID: 34402381 DOI: 10.1080/09553002.2021.1969051] [Reference Citation Analysis]
39 Yamazaki T, Wennerberg E, Hensler M, Buqué A, Kraynak J, Fucikova J, Zhou XK, Sveinbjørnsson B, Rekdal Ø, Demaria S, Galluzzi L. LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology 2021;10:1962592. [PMID: 34408925 DOI: 10.1080/2162402X.2021.1962592] [Reference Citation Analysis]
40 Fu X, He Y, Li M, Huang Z, Najafi M. Targeting of the tumor microenvironment by curcumin. Biofactors 2021. [PMID: 34375483 DOI: 10.1002/biof.1776] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
41 Banstola A, Poudel K, Kim JO, Jeong JH, Yook S. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. J Control Release 2021;337:505-20. [PMID: 34314800 DOI: 10.1016/j.jconrel.2021.07.038] [Reference Citation Analysis]
42 Mirjolet C, Nicol A, Limagne E, Mura C, Richard C, Morgand V, Rousseau M, Boidot R, Ghiringhelli F, Noel G, Burckel H. Impact of proton therapy on antitumor immune response. Sci Rep 2021;11:13444. [PMID: 34188135 DOI: 10.1038/s41598-021-92942-1] [Reference Citation Analysis]
43 Saito RF, Rangel MC, Halman JR, Chandler M, de Sousa Andrade LN, Odete-Bustos S, Furuya TK, Carrasco AGM, Chaves-Filho AB, Yoshinaga MY, Miyamoto S, Afonin KA, Chammas R. Simultaneous silencing of lysophosphatidylcholine acyltransferases 1-4 by nucleic acid nanoparticles (NANPs) improves radiation response of melanoma cells. Nanomedicine 2021;36:102418. [PMID: 34171470 DOI: 10.1016/j.nano.2021.102418] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Mu Q, Najafi M. Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells. Int Immunopharmacol 2021;98:107895. [PMID: 34171623 DOI: 10.1016/j.intimp.2021.107895] [Reference Citation Analysis]
45 Wang J, Han Q, Liu H, Luo H, Li L, Liu A, Jiang Y. Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach. Front Mol Biosci 2021;8:624575. [PMID: 34212001 DOI: 10.3389/fmolb.2021.624575] [Reference Citation Analysis]
46 Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, Galluzzi L. ATP and cancer immunosurveillance. EMBO J 2021;40:e108130. [PMID: 34121201 DOI: 10.15252/embj.2021108130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Berzaghi R, Tornaas S, Lode K, Hellevik T, Martinez-Zubiaurre I. Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells. Front Immunol 2021;12:662594. [PMID: 34177901 DOI: 10.3389/fimmu.2021.662594] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Deutsch E, Cengel KA, Galluzzi L, Levy A. Could Protons Promote Tumor Control by Avoiding Lymphopenia? J Thorac Oncol 2021;16:e39-41. [PMID: 34034888 DOI: 10.1016/j.jtho.2021.01.1614] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Huang Z, Yao D, Ye Q, Jiang H, Gu R, Ji C, Wu J, Hu Y, Yuan A. Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment. ACS Nano 2021;15:8450-65. [PMID: 33938751 DOI: 10.1021/acsnano.0c10764] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
50 Sia J, Hagekyriakou J, Chindris I, Albarakati H, Leong T, Schlenker R, Keam SP, Williams SG, Neeson PJ, Johnstone RW, Haynes NM. Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses. Int J Radiat Oncol Biol Phys 2021;111:502-14. [PMID: 34023423 DOI: 10.1016/j.ijrobp.2021.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Zhang H, Jiang H, Zhu L, Li J, Ma S. Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives. Cancer Lett 2021;514:38-47. [PMID: 34019960 DOI: 10.1016/j.canlet.2021.05.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Sato A, Buque A, Yamazaki T, Bloy N, Petroni G, Galluzzi L. Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells. STAR Protoc 2021;2:100488. [PMID: 34041502 DOI: 10.1016/j.xpro.2021.100488] [Reference Citation Analysis]
53 Constanzo J, Faget J, Ursino C, Badie C, Pouget JP. Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway. Front Immunol 2021;12:680503. [PMID: 34079557 DOI: 10.3389/fimmu.2021.680503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Galluzzi L, Garg AD. Immunology of Cell Death in Cancer Immunotherapy. Cells 2021;10:1208. [PMID: 34063358 DOI: 10.3390/cells10051208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Herskind C, Barcellos-Hoff MH. Editorial: Cell Signaling Mediating Critical Radiation Responses. Front Oncol 2021;11:695355. [PMID: 34041040 DOI: 10.3389/fonc.2021.695355] [Reference Citation Analysis]
56 Cruz-Garcia L, Badie C, Anbalagan S, Moquet J, Gothard L, O'Brien G, Somaiah N, Ainsbury EA. An ionising radiation-induced specific transcriptional signature of inflammation-associated genes in whole blood from radiotherapy patients: a pilot study. Radiat Oncol 2021;16:83. [PMID: 33941218 DOI: 10.1186/s13014-021-01807-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Jablonska PA, Bosch-Barrera J, Serrano D, Valiente M, Calvo A, Aristu J. Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:2141. [PMID: 33946751 DOI: 10.3390/cancers13092141] [Reference Citation Analysis]
58 Sangro B, Sarobe P, Hervás-Stubbs S, Melero I. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021;18:525-43. [PMID: 33850328 DOI: 10.1038/s41575-021-00438-0] [Cited by in Crossref: 127] [Cited by in F6Publishing: 103] [Article Influence: 127.0] [Reference Citation Analysis]
59 Zhao Y, Zhang T, Wang Y, Lu D, Du J, Feng X, Zhou H, Liu N, Zhu H, Qin S, Liu C, Gao X, Yang Z, Liu Z. ICAM-1 orchestrates the abscopal effect of tumor radiotherapy. Proc Natl Acad Sci U S A 2021;118:e2010333118. [PMID: 33785590 DOI: 10.1073/pnas.2010333118] [Reference Citation Analysis]
60 Genoud V, Migliorini D. Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies. Int J Mol Sci 2021;22:3493. [PMID: 33800593 DOI: 10.3390/ijms22073493] [Reference Citation Analysis]
61 Sanchez-Cano C, Alvarez-Puebla RA, Abendroth JM, Beck T, Blick R, Cao Y, Caruso F, Chakraborty I, Chapman HN, Chen C, Cohen BE, Conceição ALC, Cormode DP, Cui D, Dawson KA, Falkenberg G, Fan C, Feliu N, Gao M, Gargioni E, Glüer CC, Grüner F, Hassan M, Hu Y, Huang Y, Huber S, Huse N, Kang Y, Khademhosseini A, Keller TF, Körnig C, Kotov NA, Koziej D, Liang XJ, Liu B, Liu S, Liu Y, Liu Z, Liz-Marzán LM, Ma X, Machicote A, Maison W, Mancuso AP, Megahed S, Nickel B, Otto F, Palencia C, Pascarelli S, Pearson A, Peñate-Medina O, Qi B, Rädler J, Richardson JJ, Rosenhahn A, Rothkamm K, Rübhausen M, Sanyal MK, Schaak RE, Schlemmer HP, Schmidt M, Schmutzler O, Schotten T, Schulz F, Sood AK, Spiers KM, Staufer T, Stemer DM, Stierle A, Sun X, Tsakanova G, Weiss PS, Weller H, Westermeier F, Xu M, Yan H, Zeng Y, Zhao Y, Zhao Y, Zhu D, Zhu Y, Parak WJ. X-ray-Based Techniques to Study the Nano-Bio Interface. ACS Nano 2021;15:3754-807. [PMID: 33650433 DOI: 10.1021/acsnano.0c09563] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
62 Mo Y, Zhang B, Pan Y, Qin Q, Ye Y, Li X, Huang L, Jiang W. Impact of the weekday of the first intensity-modulated radiotherapy treatment on the survival outcomes of patients with nasopharyngeal carcinoma: A multicenter cohort study. Oral Oncol 2021;116:105258. [PMID: 33706048 DOI: 10.1016/j.oraloncology.2021.105258] [Reference Citation Analysis]
63 Petroni G, Galluzzi L. Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents. Oncoimmunology 2021;10:1889101. [PMID: 33659100 DOI: 10.1080/2162402X.2021.1889101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Lv Y, Wang H, Li G, Zhao B. Three-dimensional decellularized tumor extracellular matrices with different stiffness as bioengineered tumor scaffolds. Bioact Mater 2021;6:2767-82. [PMID: 33665508 DOI: 10.1016/j.bioactmat.2021.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Yamazaki T, Bravo-San Pedro JM, Galluzzi L, Kroemer G, Pietrocola F. Autophagy in the cancer-immunity dialogue. Adv Drug Deliv Rev 2021;169:40-50. [PMID: 33301821 DOI: 10.1016/j.addr.2020.12.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
66 Keisari Y, Kelson I. The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules. Cells 2021;10:228. [PMID: 33503958 DOI: 10.3390/cells10020228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Petroni G, Buqué A, Yamazaki T, Bloy N, Liberto MD, Chen-Kiang S, Formenti SC, Galluzzi L. Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer. Clin Cancer Res 2021;27:1855-63. [PMID: 33495311 DOI: 10.1158/1078-0432.CCR-20-3871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
68 Vitale I, Yamazaki T, Wennerberg E, Sveinbjørnsson B, Rekdal Ø, Demaria S, Galluzzi L. Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. Trends Cancer 2021;7:557-72. [PMID: 33446447 DOI: 10.1016/j.trecan.2020.12.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Xiao L, Mao Y, Tong Z, Zhao Y, Hong H, Wang F. Radiation exposure triggers the malignancy of non‑small cell lung cancer cells through the activation of visfatin/Snail signaling. Oncol Rep 2021;45:1153-61. [PMID: 33432364 DOI: 10.3892/or.2021.7929] [Reference Citation Analysis]
70 Ahluwalia P, Ahluwalia M, Mondal AK, Sahajpal N, Kota V, Rojiani MV, Rojiani AM, Kolhe R. Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer. Cancers (Basel) 2021;13:E155. [PMID: 33466402 DOI: 10.3390/cancers13010155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
71 Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell 2021;39:310-45. [PMID: 33338426 DOI: 10.1016/j.ccell.2020.11.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
72 Shcherbakov V, Denisov SA, Mostafavi M. On the Primary Water Radicals' Production in the Presence of Gold Nanoparticles: Electron Pulse Radiolysis Study. Nanomaterials (Basel) 2020;10:E2478. [PMID: 33321905 DOI: 10.3390/nano10122478] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Yu J, Xie M, Ge S, Chai P, Zhou Y, Ruan J. Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling. Front Oncol 2020;10:580029. [PMID: 33330057 DOI: 10.3389/fonc.2020.580029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis 2020;11:1013. [PMID: 33243969 DOI: 10.1038/s41419-020-03221-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
75 Ragunathan K, Upfold NLE, Oksenych V. Interaction between Fibroblasts and Immune Cells Following DNA Damage Induced by Ionizing Radiation. Int J Mol Sci 2020;21:E8635. [PMID: 33207781 DOI: 10.3390/ijms21228635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Kepp O, Kroemer G. Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in! Oncoimmunology 2020;9:1846358. [PMID: 33244441 DOI: 10.1080/2162402X.2020.1846358] [Reference Citation Analysis]
77 Pilones KA, Hensler M, Daviaud C, Kraynak J, Fucikova J, Galluzzi L, Demaria S, Formenti SC. Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade. Oncoimmunology 2020;9:1830524. [PMID: 33150045 DOI: 10.1080/2162402X.2020.1830524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
78 Ma Y, Zhan S, Lu H, Wang R, Xu Y, Zhang G, Cao L, Shi T, Zhang X, Chen W. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer. Cell Death Dis 2020;11:824. [PMID: 33011740 DOI: 10.1038/s41419-020-03041-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
79 Wang W, Zou W. Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy. Mol Cell 2020;80:384-95. [PMID: 32997964 DOI: 10.1016/j.molcel.2020.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
80 Marchi S, Giorgi C, Galluzzi L, Pinton P. Ca2+ Fluxes and Cancer. Mol Cell 2020;78:1055-69. [PMID: 32559424 DOI: 10.1016/j.molcel.2020.04.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 17.5] [Reference Citation Analysis]
81 Petroni G, Vitale I, Galluzzi L. Caspase 2 and p53 Reunited in Tumor Control. Trends Cell Biol 2020;30:917-8. [PMID: 32921524 DOI: 10.1016/j.tcb.2020.09.001] [Reference Citation Analysis]
82 Dong S, Luo C, Hu X, Zhang J, Cai Q, Qian Y, Ran F, Ou W, Wang J, Huang Q, Ren T, Han G, Zhang F, Wei W, Liang X, Xu H, Wang S, Shi L, Wei S, Hu S. Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2. Front Oncol 2020;10:1555. [PMID: 33014801 DOI: 10.3389/fonc.2020.01555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
83 Yamazaki T, Kirchmair A, Sato A, Buqué A, Rybstein M, Petroni G, Bloy N, Finotello F, Stafford L, Navarro Manzano E, Ayala de la Peña F, García-Martínez E, Formenti SC, Trajanoski Z, Galluzzi L. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nat Immunol 2020;21:1160-71. [PMID: 32747819 DOI: 10.1038/s41590-020-0751-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 26.5] [Reference Citation Analysis]
84 Yamazaki T, Galluzzi L. Mitochondrial control of innate immune signaling by irradiated cancer cells. Oncoimmunology 2020;9:1797292. [PMID: 32923160 DOI: 10.1080/2162402X.2020.1797292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
85 Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O. Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. Oncoimmunology 2020;9:1796002. [PMID: 32934889 DOI: 10.1080/2162402X.2020.1796002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
86 Wang H, Li X, Peng R, Wang Y, Wang J. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis. Semin Cancer Biol 2021;71:21-32. [PMID: 32629077 DOI: 10.1016/j.semcancer.2020.06.018] [Reference Citation Analysis]
87 Jarosz-Biej M, Smolarczyk R, Cichoń T, Drzyzga A, Czapla J, Urbaś Z, Pilny E, Matuszczak S, Wojcieszek P. Brachytherapy in a Single Dose of 10Gy as an "in situ" Vaccination. Int J Mol Sci 2020;21:E4585. [PMID: 32605154 DOI: 10.3390/ijms21134585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Chevalier B, Pasquier D, Lartigau EF, Chargari C, Schernberg A, Jannin A, Mirabel X, Vantyghem MC, Escande A. Metformin: (future) best friend of the radiation oncologist? Radiother Oncol 2020;151:95-105. [PMID: 32592892 DOI: 10.1016/j.radonc.2020.06.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
89 Chen J, Liu X, Zeng Z, Li J, Luo Y, Sun W, Gong Y, Zhang J, Wu Q, Xie C. Immunomodulation of NK Cells by Ionizing Radiation. Front Oncol 2020;10:874. [PMID: 32612950 DOI: 10.3389/fonc.2020.00874] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
90 Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G. Trial watch: STING agonists in cancer therapy. Oncoimmunology 2020;9:1777624. [PMID: 32934881 DOI: 10.1080/2162402X.2020.1777624] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 15.5] [Reference Citation Analysis]
91 Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: TLR3 agonists in cancer therapy. Oncoimmunology 2020;9:1771143. [PMID: 32934877 DOI: 10.1080/2162402X.2020.1771143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
92 Liang H, Shen X. LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells. Biochem Biophys Res Commun 2020;528:330-5. [PMID: 32448508 DOI: 10.1016/j.bbrc.2020.04.137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
93 Song KH, Jung SY, Park JI, Ahn J, Park JK, Hwang SG, Kim EH, Nam SY, Park S, Ha H, Song JY. Evaluation of Anti-Tumor Effects of Whole-Body Low-Dose Irradiation in Metastatic Mouse Models. Cancers (Basel) 2020;12:E1126. [PMID: 32365904 DOI: 10.3390/cancers12051126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Chong SJF, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S. Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends Cell Biol 2020;30:537-55. [PMID: 32307222 DOI: 10.1016/j.tcb.2020.03.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
95 Goedegebuure RSA, Vonk C, Kooij LP, Derks S, Thijssen VLJL. Combining Radiation Therapy With Interferons: Back to the Future. Int J Radiat Oncol Biol Phys 2020;108:56-69. [PMID: 32068114 DOI: 10.1016/j.ijrobp.2020.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]